ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

No reported Accounts Receivables figures are available to summarize.

Accounts Receivables history

Currency unavailable · from the cash flow

No Accounts Receivables data reported for this period type.

Accounts Receivables vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Accounts Receivables for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$13.31M USD+6.6%—29.4%
MGTXMeiraGTx Holdings plcLTM Mar 2026$13.03M USD-178.8%—16.3%
SLNSilence Therapeutics plcLTM Mar 2026$8.33M USD——904.4%
STOKStoke Therapeutics, Inc.LTM Mar 2026$4.8M USD+1478.7%—15.0%
WVEWave Life Sciences Ltd.LTM Mar 2026$177.78K USD+291.8%—0.2%
PRMEPrime Medicine, Inc.LTM Mar 2026$17K USD+200.0%—0.4%
BNTCBenitec Biopharma Inc.LTM Mar 2026$8.07K USD-96.4%+481.9%—
PRQRProQR Therapeutics N.V.LTM Mar 2026€0 EUR——0.0%
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+103.3%+481.9%7.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.